BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1683974)

  • 1. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?
    Nava E; Palmer RM; Moncada S
    Lancet; 1991 Dec 21-28; 338(8782-8783):1555-7. PubMed ID: 1683974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
    Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
    Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock.
    Petros A; Bennett D; Vallance P
    Lancet; 1991 Dec 21-28; 338(8782-8783):1557-8. PubMed ID: 1720856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock.
    Klemm P; Thiemermann C; Winklmaier G; Martorana PA; Henning R
    Br J Pharmacol; 1995 Jan; 114(2):363-8. PubMed ID: 7533615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective and pathological roles of nitric oxide in endotoxin shock.
    Wright CE; Rees DD; Moncada S
    Cardiovasc Res; 1992 Jan; 26(1):48-57. PubMed ID: 1516112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis.
    Kilbourn RG; Jubran A; Gross SS; Griffith OW; Levi R; Adams J; Lodato RF
    Biochem Biophys Res Commun; 1990 Nov; 172(3):1132-8. PubMed ID: 2244897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of refractory hypotension in septic shock by inhibitor of nitric oxide synthase.
    Lin PJ; Chang CH; Chang JP
    Chest; 1994 Aug; 106(2):626-9. PubMed ID: 7539733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation.
    Statman R; Cheng W; Cunningham JN; Henderson JL; Damiani P; Siconolfi A; Rogers D; Horovitz JH
    J Surg Res; 1994 Jul; 57(1):93-8. PubMed ID: 8041156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is endotoxin-induced hypotension related to nitric oxide formation?
    Preiser JC; Zhang H; Wachel D; Boeynaems JM; Buurman W; Vincent JL
    Eur Surg Res; 1994; 26(1):10-8. PubMed ID: 7511103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of nitric oxide in endotoxic shock: effects of NG-monomethyl-L-arginine.
    Nava E; Palmer RM; Moncada S
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S132-4. PubMed ID: 1282948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the production of nitric oxide and vasodilator prostaglandins attenuates the cardiovascular response to bacterial endotoxin in adrenalectomized rats.
    Szabó C; Thiemermann C; Vane JR
    Proc Biol Sci; 1993 Sep; 253(1338):233-8. PubMed ID: 7694300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.
    Schilling J; Cakmakci M; Bättig U; Geroulanos S
    Intensive Care Med; 1993; 19(4):227-31. PubMed ID: 7690053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo quantification of endotoxin-induced nitric oxide production in pigs from Na15NO3-infusion.
    Santak B; Radermacher P; Iber T; Adler J; Wachter U; Vassilev D; Georgieff M; Vogt J
    Br J Pharmacol; 1997 Dec; 122(8):1605-10. PubMed ID: 9422804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs.
    Kilbourn RG; Cromeens DM; Chelly FD; Griffith OW
    Crit Care Med; 1994 Nov; 22(11):1835-40. PubMed ID: 7956289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse.
    Rees DD; Monkhouse JE; Cambridge D; Moncada S
    Br J Pharmacol; 1998 Jun; 124(3):540-6. PubMed ID: 9647479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs.
    Cobb JP; Natanson C; Quezado ZM; Hoffman WD; Koev CA; Banks S; Correa R; Levi R; Elin RJ; Hosseini JM
    Am J Physiol; 1995 Apr; 268(4 Pt 2):H1634-42. PubMed ID: 7733365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nitric oxide synthase inhibitors on systemic hypotension, cytokines and inducible nitric oxide synthase expression and lung injury following endotoxin administration in rats.
    Wang D; Wei J; Hsu K; Jau J; Lieu MW; Chao TJ; Chen HI
    J Biomed Sci; 1999 Jan; 6(1):28-35. PubMed ID: 9933740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of nitric oxide synthase inhibitors as a novel treatment for septic shock.
    Wolfe TA; Dasta JF
    Ann Pharmacother; 1995 Jan; 29(1):36-46. PubMed ID: 7536056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of nitric oxide synthesis induces a significant reduction in local cerebral blood flow in the rat.
    Tanaka K; Gotoh F; Gomi S; Takashima S; Mihara B; Shirai T; Nogawa S; Nagata E
    Neurosci Lett; 1991 Jun; 127(1):129-32. PubMed ID: 1881609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cyclic guanosine monophosphate production during Escherichia coli septic shock.
    Rosenberg RB; Broner CW; O'Dorisio MS
    Biochem Med Metab Biol; 1994 Apr; 51(2):149-55. PubMed ID: 8043298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.